Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression
Part of paid clinical trials in Tulsa, Oklahoma.
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Study ID
- NCT06088732
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Bipolar Depression
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- Exercise Session — OTHER30 min cycling on bicycle ergometer at 60% peak power output
- Ibuprofen 800 mg — DRUGA single oral dose of Ibuprofen
- Rest — OTHERResting for 30 min in chair
- Placebo — DRUGMatched placebo
Study Details
This is a 2x2, within-subjects, cross-over trial to test the anti-depressant effects of acute exercise in 20 participants with bipolar depression. Participants will complete four experimental sessions, two with an exercise challenge and two with a resting control condition in a counterbalanced order. Participants will receive either 800mg of ibuprofen or placebo before exercise or rest in order to test whether blocking the inflammatory response to exercise interferes with the neural and psychological effects of exercise.
Key Dates
- Start date
- Mar 12, 2024
- Status verified
- May 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Session 1Exercise (30 min on bicycle ergometer at 60% peak power output) and a single oral dose 800mg of ibuprofen
- Active Comparator: Session 2Exercise (30 min on bicycle ergometer at 60% peak power output) and matching placebo
- Active Comparator: Session 330 minutes rest (sitting in chair) and a single oral dose 800mg of ibuprofen
- Placebo Comparator: Session 430 minutes rest (sitting in chair) and matching placebo
Primary Outcome Measure
Inflammation [ Time Frame: Difference between IL-6 at baseline and two hours post intervention ]
Central Contacts
- Jonathan Savitz9185025104
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Laureate Institute for Brain Research | Tulsa | Oklahoma | 74136 |
Find similar trials in Tulsa, OK
By research site
Related Studies
- Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPHASE3 · Recruiting · Intra-Cellular Therapies, Inc. · Dothan, Alabama
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar DisorderEARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- University of Iowa Interventional Psychiatry Service Patient RegistryRecruiting · Mark Niciu · Iowa City, Iowa
- Deep Brain Stimulation of Treatment-Resistant Bipolar DepressionRecruiting · Wayne Goodman MD · Boston, Massachusetts